News
2d
Clinical Trials Arena on MSNSabin Vaccine Institute begins trial of vaccine candidate for Marburg virus diseaseThe Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.
Yesterday, the US Centers for Disease Control and Prevention (CDC) issued a level 2 travel notice (practice enhanced ...
A review of 600 US patients treated for suspected sepsis found 32% most likely didn't have a bacterial infection, while ...
Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...
Currently, there are no approved vaccines for Marburg virus disease.
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
Dr. Ngashi Ngongo, the Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the official handover ceremony in Luanda.
9d
AllAfrica on MSNBurundi Revises Outbreak Response Plans [press release]Burundi has revised and approved its Mpox Response Plan and Marburg-Ebola Preparedness Plan, signaling a high-level commitment to strengthening outbreak response efforts in the country.A validation ...
The allowed claims generally cover prevention of Marburg virus infection utilizing GeoVax’s proprietary MVA-based Marburg vaccine. Previous presentations of data from nonhuman primate studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results